KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other financing activities (2017 - 2021)

Twist Bioscience (TWST) has disclosed Other financing activities for 4 consecutive years, with -$2.6 million as the latest value for Q4 2021.

  • Quarterly Other financing activities fell 6.14% to -$2.6 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$11.0 million through Dec 2021, down 173.35% year-over-year, with the annual reading at -$10.8 million for FY2021, 348.12% down from the prior year.
  • Other financing activities for Q4 2021 was -$2.6 million at Twist Bioscience, up from -$2.6 million in the prior quarter.
  • The five-year high for Other financing activities was $1.4 million in Q1 2018, with the low at -$3.3 million in Q1 2021.
  • Average Other financing activities over 4 years is -$1.1 million, with a median of -$611500.0 recorded in 2020.
  • Peak annual rise in Other financing activities hit 6.14% in 2021, while the deepest fall reached 756.67% in 2021.
  • Over 4 years, Other financing activities stood at $470000.0 in 2017, then decreased by 7.66% to $434000.0 in 2018, then plummeted by 655.3% to -$2.4 million in 2020, then decreased by 6.14% to -$2.6 million in 2021.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$2.6 million, -$2.6 million, and -$2.5 million for Q4 2021, Q3 2021, and Q2 2021 respectively.